OMNIDAB
Dead / Abandoned — Abandoned — no statement of use filed (as of 11 Oct 2021)
What this means for you
This application is over — abandoned 11 Oct 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87880219
- Mark type
- Stylized text
- Filed
- 17 Apr 2018
- Published for opposition
- 10 Jul 2018
- Abandoned
- 11 Oct 2021
- Attorney of record
- Lisa M. Martens
Goods and services
- Class 001 — Chemicals: Laboratory chemicals, namely, antibodies for use in scientific and medical research
- Class 042 — Scientific and technological services: Scientific research and development; scientific research and development in the field of immunization and antibody screening
Owner
- Ligand Pharmaceuticals Incorporated, San Diego, CA, US
- Ligand Pharmaceuticals, Inc., San Diego, CA, US
Prosecution history
- 12 Oct 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Oct 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 23 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jun 2021 — SOU EXTENSION 5 GRANTED
- 24 Feb 2021 — SOU EXTENSION 5 FILED
- 22 Jun 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Feb 2021 — SOU TEAS EXTENSION RECEIVED
- 29 Aug 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Aug 2020 — SOU EXTENSION 4 GRANTED
- 27 Aug 2020 — SOU EXTENSION 4 FILED
- 27 Aug 2020 — SOU TEAS EXTENSION RECEIVED
- 28 Jan 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jan 2020 — SOU EXTENSION 3 GRANTED
- 21 Jan 2020 — SOU EXTENSION 3 FILED
- 21 Jan 2020 — SOU TEAS EXTENSION RECEIVED